{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:07:27Z","timestamp":1783944447652,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/ncpendmet0693","type":"journal-article","created":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T14:42:31Z","timestamp":1195483351000},"page":"835-840","source":"Crossref","is-referenced-by-count":31,"title":["A patient with type B insulin resistance syndrome, responsive to immune therapy"],"prefix":"10.1038","volume":"3","author":[{"given":"Kathleen A","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dejardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Ronald","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit N","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan C","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio E","family":"Inzucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0693_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ncpendmet0426","volume":"3","author":"L Langouche","year":"2007","unstructured":"Langouche L  et al. (2007) Therapy Insight: the effect of tight glycemic control in acute illness. Nat Clin Pract Endocrinol Metab 3: 270\u2013278","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"BFncpendmet0693_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/MCO.0b013e32801481df","volume":"10","author":"M Soop","year":"2007","unstructured":"Soop M  et al. (2007) Stress-induced insulin resistance: recent developments. Curr Opin Clin Nutr Metab Care 10: 181\u2013186","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFncpendmet0693_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.286.16.1945","volume":"286","author":"B Luna","year":"2001","unstructured":"Luna B and Feinglos M (2001) Drug-induced hyperglycemia. JAMA 286: 1945\u20131948","journal-title":"JAMA"},{"key":"BFncpendmet0693_CR4","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1056\/NEJMoa055191","volume":"354","author":"L Park-Wyllie","year":"2006","unstructured":"Park-Wyllie L  et al. (2006) Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 354: 1352\u20131361","journal-title":"N Engl J Med"},{"key":"BFncpendmet0693_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.clinthera.2006.11.014","volume":"28","author":"C Yip","year":"2006","unstructured":"Yip C and Lee AJ (2006) Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature. Clin Ther 28: 1857\u20131866","journal-title":"Clin Ther"},{"key":"BFncpendmet0693_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW (2005) Second-generation (atypical antipsychotics) and metabolic effects. A comprehensive literature review. CNS Drugs 19: 1\u201393","journal-title":"CNS Drugs"},{"key":"BFncpendmet0693_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1056\/NEJM197604012941401","volume":"294","author":"CR Kahn","year":"1976","unstructured":"Kahn CR  et al. (1976) The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 294: 739\u2013745","journal-title":"N Engl J Med"},{"key":"BFncpendmet0693_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","volume":"81","author":"E Arioglu","year":"2002","unstructured":"Arioglu E  et al. (2002) Clinical course of the syndrome of autoantibodies to the insulin receptor (Type B insulin resistance): a 28-year perspective. Medicine 81: 87\u2013100","journal-title":"Medicine"},{"key":"BFncpendmet0693_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0889-8529(18)30392-X","volume":"18","author":"S Taylor","year":"1989","unstructured":"Taylor S  et al. (1989) Syndromes of autoimmunity and hypoglycemia. Endocrinol Metab Clin North Am 18: 123\u2013143","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFncpendmet0693_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4158\/EP.13.1.51","volume":"13","author":"S Bao","year":"2007","unstructured":"Bao S  et al. (2007) Type B insulin resistance syndrome associated with systemic lupus erythematosus. Endocr Pract 13: 51\u201354","journal-title":"Endocr Pract"},{"key":"BFncpendmet0693_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/00007611-199907000-00013","volume":"92","author":"C Magsino","year":"1999","unstructured":"Magsino C and Spencer J (1999) Insulin receptor antibodies and insulin resistance. South Med J 92: 717\u2013719","journal-title":"South Med J"},{"key":"BFncpendmet0693_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2337\/diacare.21.8.1217","volume":"21","author":"J Eriksson","year":"1998","unstructured":"Eriksson J  et al. (1998) Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Diabetes Care 21: 1217\u20131220","journal-title":"Diabetes Care"},{"key":"BFncpendmet0693_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1210\/jcem-44-1-15","volume":"44","author":"Y Kawanishi","year":"1976","unstructured":"Kawanishi Y  et al. (1976) Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies. J Clin Endocrinol Metab 44: 15\u201320","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0693_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1056\/NEJM200401153500324","volume":"350","author":"A Coll","year":"2004","unstructured":"Coll A  et al. (2004) Rituximab therapy for the type B syndrome of insulin resistance. N Engl J Med 350: 310\u2013311","journal-title":"N Engl J Med"},{"key":"BFncpendmet0693_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/art.10879","volume":"48","author":"A Gehi","year":"2003","unstructured":"Gehi A  et al. (2003) Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil. Arthritis Rheum 48: 1067\u20131070","journal-title":"Arthritis Rheum"},{"key":"BFncpendmet0693_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.metabol.2006.12.016","volume":"56","author":"GG Fareau","year":"2007","unstructured":"Fareau GG  et al. (2007) Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism 56: 670\u2013675","journal-title":"Metabolism"},{"key":"BFncpendmet0693_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1172\/JCI108832","volume":"60","author":"JS Flier","year":"1977","unstructured":"Flier JS  et al. (1977) Autoantibodies to the Insulin Receptor. Effect on the insulin receptor interaction in IM-9 lymphocytes. J Clin Invest 60: 784\u2013794","journal-title":"J Clin Invest"},{"key":"BFncpendmet0693_CR18","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1172\/JCI108600","volume":"58","author":"JS Flier","year":"1976","unstructured":"Flier JS  et al. (1976) Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. J Clin Invest 58: 1442\u20131449","journal-title":"J Clin Invest"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0693","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:54:44Z","timestamp":1684439684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["BFncpendmet0693"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0693","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}